<DOC>
	<DOCNO>NCT00670423</DOCNO>
	<brief_summary>The purpose study determine high dose bortezomib , new drug graft-versus host disease prevention , give combination sirolimus Tacrolimus , without cause severe side effect . This research do treatment 100 % effective preventing graft versus host disease . The goal study : 1 . Collect peripheral blood stem cell ( PBSCs ) donor transplant . 2 . Determine large possible dose bortezomib give recipient various blood cancer safe manner . 3 . Monitor recipient risk infection side affect associate transplant . 4 . Monitor recipient increase immunity follow transplantation .</brief_summary>
	<brief_title>A Study Using Tacrolimus , Sirolimus Bortezomib Acute Graft Versus Host Disease ( GVHD ) Prophylaxis Allogeneic Peripheral Blood Stem Cell ( PBSC ) Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Bortezomib</mesh_term>
	<criteria>Undergoing myeloablative peripheral blood stem cell transplantation Have HLA matchedrelated matchedunrelated donor ( 9/10 antigen allelic mismatch 10/10 HLA match permit ) . Hematological malignancy include patient : AML , ALL , NHL , Hodgkin 's Disease , CLL , CML , MDS Multiple Myeloma Meeting institutional standard criterion allogeneic PBSC transplantation Patient &gt; Grade 2 peripheral neuropathy within 14 day enrollment . History autologous allogeneic transplantation Evidence HIV seropositivity Evidence active infection Patients cardiac dysfunction describe protocol Patients hypersensitivity bortezomib , boron mannitol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Tacrolimus</keyword>
	<keyword>Sirolimus</keyword>
	<keyword>Bortezomib</keyword>
	<keyword>Acute Graft Versus Host Disease</keyword>
	<keyword>Allogeneic Peripheral Blood Stem Cell Transplantation</keyword>
</DOC>